Literature DB >> 9590711

Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass.

M Nakayama1, K Kumon, N Yahagi, M Haruna, Y Watanabe, H Hayashi.   

Abstract

A patient who underwent redo coronary artery bypass grafting developed severe thrombocytopenia. A platelet transfusion caused recurrent hypotension and hypoxia. The patient status was complicated by a systemic thrombosis including coronary graft occlusion and central vein thrombosis. We found that the lupus anticoagulant, as well as other autoimmune antibodies, was positive only after the thrombotic episode developed. Even though the lupus anticoagulant returned to negative about 2 months after the episode of graft occlusion, the patient eventually died of heart failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590711     DOI: 10.1007/s005950050155

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

1.  Coronary artery vasculitis and myocardial infarction associated with antiphospholipid antibodies in a pregnant woman.

Authors:  P Rallings; T Exner; R Abraham
Journal:  Aust N Z J Med       Date:  1989-08

2.  Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin.

Authors:  L D Carreras; G N Perez; H R Vega; F Casavilla
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

3.  Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid.

Authors:  R A Asherson; I R Mackay; E N Harris
Journal:  Br Heart J       Date:  1986-08

4.  Interference with anticoagulation monitoring by procainamide-induced lupus anticoagulant.

Authors:  M T Metzdorff; K S Hanses; G L Wright; S J Fried
Journal:  Ann Thorac Surg       Date:  1996-03       Impact factor: 4.330

5.  Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal.

Authors:  R A Asherson; J K Chan; E N Harris; A E Gharavi; G R Hughes
Journal:  Ann Rheum Dis       Date:  1985-12       Impact factor: 19.103

6.  A possible role for antiphospholipid antibodies in acquired cardiac valve deformity.

Authors:  S E Ford; E J Charrette; J Knight; J Pym; P Ford
Journal:  J Rheumatol       Date:  1990-11       Impact factor: 4.666

7.  Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.

Authors:  J L Vianna; M A Khamashta; J Ordi-Ros; J Font; R Cervera; A Lopez-Soto; C Tolosa; J Franz; A Selva; M Ingelmo
Journal:  Am J Med       Date:  1994-01       Impact factor: 4.965

8.  Antiphospholipid antibodies and ischaemic heart disease.

Authors:  P Jørgensen; P R Hansen
Journal:  J Intern Med       Date:  1993-03       Impact factor: 8.989

9.  Coronary artery bypass graft failure--an autoimmune phenomenon?

Authors:  K E Morton; T P Gavaghan; S A Krilis; G E Daggard; D W Baron; J B Hickie; C N Chesterman
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

Review 10.  Procainamide-induced lupus anticoagulants and thrombosis.

Authors:  G C Li; C S Greenberg; M S Currie
Journal:  South Med J       Date:  1988-02       Impact factor: 0.954

View more
  1 in total

Review 1.  Antiphospholipid syndrome; its implication in cardiovascular diseases: a review.

Authors:  Ioanna Koniari; Stavros N Siminelakis; Nikolaos G Baikoussis; Georgios Papadopoulos; John Goudevenos; Efstratios Apostolakis
Journal:  J Cardiothorac Surg       Date:  2010-11-03       Impact factor: 1.637

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.